Savara Inc (SVRA)

So, which biotech penny stocks, popular with the Reddit set, offer such opportunity? Consider these seven as ones with potential to live up to online enthusiasm.

7 Penny Stocks With Interesting Catalysts

By Josh Enomoto, InvestorPlace Contributor Apr 9, 2021

While penny stocks are always incredibly risky ventures, these publicly traded companies offer interesting catalysts to consider.

7 Reddit Penny Stocks to Keep Your Eye on for Big Movement

By Alex Sirois, InvestorPlace Contributor Mar 24, 2021

Reddit stocks -- and in particular Reddit penny stocks -- are some of the riskiest shares out there. Yet, investors could make out big with some of the names on this list.

7 Reddit Penny Stocks Seeing the Most Chatter Today

By William White, InvestorPlace Writer Mar 18, 2021

Retail investors over on Reddit Penny Stocks are showing interest in quite a few interesting players today that investors will want to note.

JMP starts Savara at buy, cites market potential for lung disease drug (NASDAQ:SVRA)

From Seeking Alpha Feb 15, 2024

JMP has started coverage of Savara (SVRA) with a buy rating, citing the market potential of its drug candidate molgramostim for the treatment of autoimmune pulm

Savara added to Nasdaq Biotechnology Index (NASDAQ:SVRA)

From Seeking Alpha Dec 20, 2023

Savara has been added to the Nasdaq Biotech Index, boosting its presence in the biotechnology industry and potentially impacting its stock performance.

Savara GAAP EPS of -$0.07 beats by $0.01 (NASDAQ:SVRA)

From Seeking Alpha Aug 10, 2023

Savara press release (SVRA): Q2 GAAP EPS of -$0.07 beats by $0.01.$105M in Cash and Cash Equivalents at the End of 2Q 2023

Savara prices $80M common stock and pre-funded warrants offering (NASDAQ:SVRA)

From Seeking Alpha Jul 13, 2023

Savara (SVRA) prices an underwritten offering of 21M common shares at $3.00 per share and 5.66M pre-funded warrants to purchase common stock at a price of $2.999 per pre-funded warrant...

Why Shares of Savara Jumped on Tuesday

From The Motley Fool May 16, 2023

The company released first-quarter earnings and said it had completed a phase 3 trial enrollment for its lead therapy.

Why Shares of Savara Soared This Week

From The Motley Fool Jan 27, 2023

The clinical-stage biopharmaceutical company focuses on therapies to treat rare respiratory diseases.

Savara Inc (SVRA)

SVRA Stock Earnings: Savara Misses EPS for Q1 2024

SVRA Stock Earnings: Savara Beats EPS for Q4 2023

The 3 Best Penny Stocks to Buy Now: September 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Savara Inc (SVRA)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

SVRA Stock Predictions, Articles, and Savara Inc News

Subscriber Sign in